Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Eagle Bancorp
EGBN
$846M
| $1.99M | ﹤0.01% |
94,080
+40,400
| +75% | +$951K |
|
2002
Kura Oncology
KURA
$800M
| $1.99M | ﹤0.01% |
188,100
+171,500
| +1,033% | +$2.03M |
|
2003
AMCON Distributing
DIT
| $1.99M | ﹤0.01% |
14,694
-180
| -1% | -$23K |
|
|
FM
2004
DELISTED
iShares Frontier and Select EM ETF
FM
| $1.99M | ﹤0.01% |
76,800
+50,400
| +191% | +$1.28M |
|
2005
Southern First Bancshares
SFST
$591M
| $1.98M | ﹤0.01% |
80,007
+8,200
| +11% | +$214K |
|
2006
First Watch Restaurant Group
FWRG
$792M
| $1.98M | ﹤0.01% |
117,100
+13,500
| +13% | +$224K |
|
2007
Northwest Natural Holdings
NWN
$2.06B
| $1.98M | ﹤0.01% |
45,946
+38,546
| +521% | +$1.74M |
|
2008
WEC Energy
WEC
$35.7B
| $1.97M | ﹤0.01% |
22,302
-228,400
| -91% | -$21.1M |
|
|
LBC
2009
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $1.97M | ﹤0.01% |
220,568
-4,200
| -2% | -$38.1K |
|
2010
HF Sinclair
DINO
$16.3B
| $1.97M | ﹤0.01% |
44,082
-433,100
| -91% | -$18.9M |
|
2011
Jack in the Box
JACK
$312M
| $1.95M | ﹤0.01% |
20,000
-138,300
| -87% | -$12.6M |
|
2012
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
| $1.95M | ﹤0.01% |
13,500
-6,600
| -33% | -$928K |
|
2013
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.5B
| $1.95M | ﹤0.01% |
85,200
+39,152
| +85% | +$889K |
|
2014
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.7B
| $1.94M | ﹤0.01% |
31,800
+2,200
| +7% | +$126K |
|
|
ADVM
2015
DELISTED
Adverum Biotechnologies
ADVM
| $1.93M | ﹤0.01% |
121,664
+7,990
| +7% | +$84K |
|
2016
Health Catalyst
HCAT
$154M
| $1.93M | ﹤0.01% |
154,600
-112,469
| -42% | -$1.34M |
|
2017
Goodyear
GT
$2B
| $1.93M | ﹤0.01% |
141,254
-1,352,600
| -91% | -$16.9M |
|
2018
CytomX Therapeutics
CTMX
$675M
| $1.93M | ﹤0.01% |
1,122,400
+272,100
| +32% | +$452K |
|
2019
Vanguard S&P 500 Growth ETF
VOOG
$25.9B
| $1.93M | ﹤0.01% |
45,600
+10,800
| +31% | +$429K |
|
2020
Equity Bancshares
EQBK
$1.04B
| $1.93M | ﹤0.01% |
84,500
-1,000
| -1% | -$23.4K |
|
|
HONE
2021
DELISTED
HarborOne Bancorp
HONE
| $1.92M | ﹤0.01% |
221,546
+51,041
| +30% | +$487K |
|
2022
CSP Inc
CSPI
$79.7M
| $1.92M | ﹤0.01% |
322,526
-3,400
| -1% | -$21.8K |
|
2023
Lennar Class B
LEN.B
$19.4B
| $1.92M | ﹤0.01% |
17,884
+316
| +2% | +$29.7K |
|
2024
Four Corners Property Trust
FCPT
$2.81B
| $1.92M | ﹤0.01% |
+75,600
| New | +$1.96M |
|
2025
Verra Mobility
VRRM
$804M
| $1.92M | ﹤0.01% |
97,300
-33,200
| -25% | -$586K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.